nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—Dactinomycin—testicular cancer	0.175	0.284	CbGbCtD
Mannitol—ABCB1—Vinblastine—testicular cancer	0.11	0.178	CbGbCtD
Mannitol—ABCB1—Cisplatin—testicular cancer	0.1	0.163	CbGbCtD
Mannitol—ABCB1—Etoposide—testicular cancer	0.0987	0.16	CbGbCtD
Mannitol—ABCB1—Doxorubicin—testicular cancer	0.0673	0.109	CbGbCtD
Mannitol—ABCB1—Methotrexate—testicular cancer	0.0652	0.106	CbGbCtD
Mannitol—Dyspnoea—Ifosfamide—testicular cancer	0.000599	0.00156	CcSEcCtD
Mannitol—Discomfort—Cisplatin—testicular cancer	0.000597	0.00156	CcSEcCtD
Mannitol—Vomiting—Vinblastine—testicular cancer	0.000592	0.00154	CcSEcCtD
Mannitol—Malaise—Etoposide—testicular cancer	0.000586	0.00153	CcSEcCtD
Mannitol—Vertigo—Etoposide—testicular cancer	0.000584	0.00152	CcSEcCtD
Mannitol—Decreased appetite—Ifosfamide—testicular cancer	0.000584	0.00152	CcSEcCtD
Mannitol—Headache—Vinblastine—testicular cancer	0.000583	0.00152	CcSEcCtD
Mannitol—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00058	0.00151	CcSEcCtD
Mannitol—Body temperature increased—Dactinomycin—testicular cancer	0.00058	0.00151	CcSEcCtD
Mannitol—Fatigue—Ifosfamide—testicular cancer	0.000579	0.00151	CcSEcCtD
Mannitol—Oedema—Cisplatin—testicular cancer	0.000579	0.00151	CcSEcCtD
Mannitol—Hypersensitivity—Bleomycin—testicular cancer	0.000579	0.00151	CcSEcCtD
Mannitol—Infection—Cisplatin—testicular cancer	0.000575	0.0015	CcSEcCtD
Mannitol—Pain—Ifosfamide—testicular cancer	0.000575	0.0015	CcSEcCtD
Mannitol—Cardiac failure—Doxorubicin—testicular cancer	0.000574	0.0015	CcSEcCtD
Mannitol—Nervous system disorder—Cisplatin—testicular cancer	0.000568	0.00148	CcSEcCtD
Mannitol—Cough—Etoposide—testicular cancer	0.000567	0.00148	CcSEcCtD
Mannitol—Tachycardia—Cisplatin—testicular cancer	0.000565	0.00147	CcSEcCtD
Mannitol—Asthenia—Bleomycin—testicular cancer	0.000564	0.00147	CcSEcCtD
Mannitol—Convulsion—Etoposide—testicular cancer	0.000563	0.00147	CcSEcCtD
Mannitol—Dehydration—Epirubicin—testicular cancer	0.000563	0.00147	CcSEcCtD
Mannitol—Skin disorder—Cisplatin—testicular cancer	0.000563	0.00147	CcSEcCtD
Mannitol—Hyponatraemia—Doxorubicin—testicular cancer	0.000562	0.00147	CcSEcCtD
Mannitol—Hypertension—Etoposide—testicular cancer	0.000561	0.00146	CcSEcCtD
Mannitol—Pain in extremity—Doxorubicin—testicular cancer	0.00056	0.00146	CcSEcCtD
Mannitol—Pruritus—Bleomycin—testicular cancer	0.000556	0.00145	CcSEcCtD
Mannitol—Feeling abnormal—Ifosfamide—testicular cancer	0.000554	0.00144	CcSEcCtD
Mannitol—Chest pain—Etoposide—testicular cancer	0.000554	0.00144	CcSEcCtD
Mannitol—Nausea—Vinblastine—testicular cancer	0.000553	0.00144	CcSEcCtD
Mannitol—Abdominal pain upper—Epirubicin—testicular cancer	0.000553	0.00144	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00055	0.00143	CcSEcCtD
Mannitol—Discomfort—Etoposide—testicular cancer	0.000547	0.00143	CcSEcCtD
Mannitol—Hypotension—Cisplatin—testicular cancer	0.000541	0.00141	CcSEcCtD
Mannitol—Nasopharyngitis—Epirubicin—testicular cancer	0.000541	0.00141	CcSEcCtD
Mannitol—Hypersensitivity—Dactinomycin—testicular cancer	0.00054	0.00141	CcSEcCtD
Mannitol—Urticaria—Ifosfamide—testicular cancer	0.000534	0.00139	CcSEcCtD
Mannitol—Body temperature increased—Ifosfamide—testicular cancer	0.000531	0.00138	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000528	0.00138	CcSEcCtD
Mannitol—Infection—Etoposide—testicular cancer	0.000527	0.00137	CcSEcCtD
Mannitol—Asthenia—Dactinomycin—testicular cancer	0.000526	0.00137	CcSEcCtD
Mannitol—Dehydration—Doxorubicin—testicular cancer	0.000521	0.00136	CcSEcCtD
Mannitol—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00052	0.00135	CcSEcCtD
Mannitol—Tachycardia—Etoposide—testicular cancer	0.000518	0.00135	CcSEcCtD
Mannitol—Dyspnoea—Cisplatin—testicular cancer	0.000516	0.00135	CcSEcCtD
Mannitol—Skin disorder—Etoposide—testicular cancer	0.000515	0.00134	CcSEcCtD
Mannitol—Abdominal pain upper—Doxorubicin—testicular cancer	0.000511	0.00133	CcSEcCtD
Mannitol—Angina pectoris—Epirubicin—testicular cancer	0.00051	0.00133	CcSEcCtD
Mannitol—Decreased appetite—Cisplatin—testicular cancer	0.000504	0.00131	CcSEcCtD
Mannitol—Bronchitis—Epirubicin—testicular cancer	0.000503	0.00131	CcSEcCtD
Mannitol—Diarrhoea—Dactinomycin—testicular cancer	0.000502	0.00131	CcSEcCtD
Mannitol—Nasopharyngitis—Doxorubicin—testicular cancer	0.000501	0.0013	CcSEcCtD
Mannitol—Gastrointestinal disorder—Cisplatin—testicular cancer	0.0005	0.0013	CcSEcCtD
Mannitol—Vomiting—Bleomycin—testicular cancer	0.0005	0.0013	CcSEcCtD
Mannitol—Infestation NOS—Methotrexate—testicular cancer	0.000498	0.0013	CcSEcCtD
Mannitol—Infestation—Methotrexate—testicular cancer	0.000498	0.0013	CcSEcCtD
Mannitol—Hypotension—Etoposide—testicular cancer	0.000496	0.00129	CcSEcCtD
Mannitol—Rash—Bleomycin—testicular cancer	0.000496	0.00129	CcSEcCtD
Mannitol—Pain—Cisplatin—testicular cancer	0.000495	0.00129	CcSEcCtD
Mannitol—Dermatitis—Bleomycin—testicular cancer	0.000495	0.00129	CcSEcCtD
Mannitol—Hypersensitivity—Ifosfamide—testicular cancer	0.000495	0.00129	CcSEcCtD
Mannitol—Renal failure—Methotrexate—testicular cancer	0.00049	0.00128	CcSEcCtD
Mannitol—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000486	0.00127	CcSEcCtD
Mannitol—Stomatitis—Methotrexate—testicular cancer	0.000486	0.00127	CcSEcCtD
Mannitol—Asthenia—Ifosfamide—testicular cancer	0.000482	0.00126	CcSEcCtD
Mannitol—Feeling abnormal—Cisplatin—testicular cancer	0.000477	0.00124	CcSEcCtD
Mannitol—Pruritus—Ifosfamide—testicular cancer	0.000475	0.00124	CcSEcCtD
Mannitol—Dyspnoea—Etoposide—testicular cancer	0.000473	0.00123	CcSEcCtD
Mannitol—Angina pectoris—Doxorubicin—testicular cancer	0.000471	0.00123	CcSEcCtD
Mannitol—Nausea—Bleomycin—testicular cancer	0.000467	0.00122	CcSEcCtD
Mannitol—Infestation—Epirubicin—testicular cancer	0.000466	0.00122	CcSEcCtD
Mannitol—Infestation NOS—Epirubicin—testicular cancer	0.000466	0.00122	CcSEcCtD
Mannitol—Vomiting—Dactinomycin—testicular cancer	0.000466	0.00121	CcSEcCtD
Mannitol—Bronchitis—Doxorubicin—testicular cancer	0.000465	0.00121	CcSEcCtD
Mannitol—Rash—Dactinomycin—testicular cancer	0.000462	0.0012	CcSEcCtD
Mannitol—Decreased appetite—Etoposide—testicular cancer	0.000461	0.0012	CcSEcCtD
Mannitol—Diarrhoea—Ifosfamide—testicular cancer	0.00046	0.0012	CcSEcCtD
Mannitol—Renal failure—Epirubicin—testicular cancer	0.000458	0.00119	CcSEcCtD
Mannitol—Gastrointestinal disorder—Etoposide—testicular cancer	0.000458	0.00119	CcSEcCtD
Mannitol—Body temperature increased—Cisplatin—testicular cancer	0.000458	0.00119	CcSEcCtD
Mannitol—Fatigue—Etoposide—testicular cancer	0.000458	0.00119	CcSEcCtD
Mannitol—Stomatitis—Epirubicin—testicular cancer	0.000455	0.00118	CcSEcCtD
Mannitol—Pain—Etoposide—testicular cancer	0.000454	0.00118	CcSEcCtD
Mannitol—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00045	0.00117	CcSEcCtD
Mannitol—Dizziness—Ifosfamide—testicular cancer	0.000444	0.00116	CcSEcCtD
Mannitol—Pharyngitis—Methotrexate—testicular cancer	0.000444	0.00116	CcSEcCtD
Mannitol—Urinary tract disorder—Methotrexate—testicular cancer	0.000442	0.00115	CcSEcCtD
Mannitol—Urethral disorder—Methotrexate—testicular cancer	0.000439	0.00114	CcSEcCtD
Mannitol—Feeling abnormal—Etoposide—testicular cancer	0.000437	0.00114	CcSEcCtD
Mannitol—Nausea—Dactinomycin—testicular cancer	0.000436	0.00113	CcSEcCtD
Mannitol—Infestation NOS—Doxorubicin—testicular cancer	0.000432	0.00112	CcSEcCtD
Mannitol—Infestation—Doxorubicin—testicular cancer	0.000432	0.00112	CcSEcCtD
Mannitol—Vomiting—Ifosfamide—testicular cancer	0.000427	0.00111	CcSEcCtD
Mannitol—Hypersensitivity—Cisplatin—testicular cancer	0.000427	0.00111	CcSEcCtD
Mannitol—Renal failure—Doxorubicin—testicular cancer	0.000424	0.00111	CcSEcCtD
Mannitol—Rash—Ifosfamide—testicular cancer	0.000424	0.0011	CcSEcCtD
Mannitol—Dermatitis—Ifosfamide—testicular cancer	0.000423	0.0011	CcSEcCtD
Mannitol—Urticaria—Etoposide—testicular cancer	0.000422	0.0011	CcSEcCtD
Mannitol—Stomatitis—Doxorubicin—testicular cancer	0.000421	0.0011	CcSEcCtD
Mannitol—Rhinitis—Epirubicin—testicular cancer	0.00042	0.00109	CcSEcCtD
Mannitol—Body temperature increased—Etoposide—testicular cancer	0.00042	0.00109	CcSEcCtD
Mannitol—Asthenia—Cisplatin—testicular cancer	0.000416	0.00108	CcSEcCtD
Mannitol—Pharyngitis—Epirubicin—testicular cancer	0.000416	0.00108	CcSEcCtD
Mannitol—Urinary tract disorder—Epirubicin—testicular cancer	0.000414	0.00108	CcSEcCtD
Mannitol—Connective tissue disorder—Epirubicin—testicular cancer	0.000411	0.00107	CcSEcCtD
Mannitol—Urethral disorder—Epirubicin—testicular cancer	0.00041	0.00107	CcSEcCtD
Mannitol—Mediastinal disorder—Methotrexate—testicular cancer	0.000403	0.00105	CcSEcCtD
Mannitol—Chills—Methotrexate—testicular cancer	0.000401	0.00105	CcSEcCtD
Mannitol—Nausea—Ifosfamide—testicular cancer	0.000399	0.00104	CcSEcCtD
Mannitol—Diarrhoea—Cisplatin—testicular cancer	0.000396	0.00103	CcSEcCtD
Mannitol—Mental disorder—Methotrexate—testicular cancer	0.000392	0.00102	CcSEcCtD
Mannitol—Hypersensitivity—Etoposide—testicular cancer	0.000391	0.00102	CcSEcCtD
Mannitol—Malnutrition—Methotrexate—testicular cancer	0.000389	0.00101	CcSEcCtD
Mannitol—Rhinitis—Doxorubicin—testicular cancer	0.000388	0.00101	CcSEcCtD
Mannitol—Pharyngitis—Doxorubicin—testicular cancer	0.000385	0.001	CcSEcCtD
Mannitol—Urinary tract disorder—Doxorubicin—testicular cancer	0.000383	0.000997	CcSEcCtD
Mannitol—Asthenia—Etoposide—testicular cancer	0.000381	0.000992	CcSEcCtD
Mannitol—Connective tissue disorder—Doxorubicin—testicular cancer	0.000381	0.000992	CcSEcCtD
Mannitol—Urethral disorder—Doxorubicin—testicular cancer	0.00038	0.00099	CcSEcCtD
Mannitol—Mediastinal disorder—Epirubicin—testicular cancer	0.000377	0.000983	CcSEcCtD
Mannitol—Back pain—Methotrexate—testicular cancer	0.000377	0.000982	CcSEcCtD
Mannitol—Chills—Epirubicin—testicular cancer	0.000376	0.000979	CcSEcCtD
Mannitol—Pruritus—Etoposide—testicular cancer	0.000375	0.000978	CcSEcCtD
Mannitol—Vomiting—Cisplatin—testicular cancer	0.000368	0.00096	CcSEcCtD
Mannitol—Vision blurred—Methotrexate—testicular cancer	0.000367	0.000956	CcSEcCtD
Mannitol—Mental disorder—Epirubicin—testicular cancer	0.000367	0.000956	CcSEcCtD
Mannitol—Rash—Cisplatin—testicular cancer	0.000365	0.000952	CcSEcCtD
Mannitol—Dermatitis—Cisplatin—testicular cancer	0.000365	0.000951	CcSEcCtD
Mannitol—Malnutrition—Epirubicin—testicular cancer	0.000364	0.00095	CcSEcCtD
Mannitol—Diarrhoea—Etoposide—testicular cancer	0.000363	0.000946	CcSEcCtD
Mannitol—Ill-defined disorder—Methotrexate—testicular cancer	0.000361	0.000942	CcSEcCtD
Mannitol—Flatulence—Epirubicin—testicular cancer	0.000359	0.000936	CcSEcCtD
Mannitol—Nervousness—Epirubicin—testicular cancer	0.000354	0.000922	CcSEcCtD
Mannitol—Back pain—Epirubicin—testicular cancer	0.000353	0.000919	CcSEcCtD
Mannitol—Malaise—Methotrexate—testicular cancer	0.000351	0.000915	CcSEcCtD
Mannitol—Dizziness—Etoposide—testicular cancer	0.000351	0.000914	CcSEcCtD
Mannitol—Vertigo—Methotrexate—testicular cancer	0.00035	0.000912	CcSEcCtD
Mannitol—Mediastinal disorder—Doxorubicin—testicular cancer	0.000349	0.00091	CcSEcCtD
Mannitol—Chills—Doxorubicin—testicular cancer	0.000348	0.000906	CcSEcCtD
Mannitol—Nausea—Cisplatin—testicular cancer	0.000344	0.000897	CcSEcCtD
Mannitol—Vision blurred—Epirubicin—testicular cancer	0.000344	0.000895	CcSEcCtD
Mannitol—Cough—Methotrexate—testicular cancer	0.00034	0.000886	CcSEcCtD
Mannitol—Mental disorder—Doxorubicin—testicular cancer	0.000339	0.000884	CcSEcCtD
Mannitol—Ill-defined disorder—Epirubicin—testicular cancer	0.000338	0.000881	CcSEcCtD
Mannitol—Convulsion—Methotrexate—testicular cancer	0.000337	0.000879	CcSEcCtD
Mannitol—Vomiting—Etoposide—testicular cancer	0.000337	0.000879	CcSEcCtD
Mannitol—Malnutrition—Doxorubicin—testicular cancer	0.000337	0.000879	CcSEcCtD
Mannitol—Rash—Etoposide—testicular cancer	0.000335	0.000872	CcSEcCtD
Mannitol—Dermatitis—Etoposide—testicular cancer	0.000334	0.000871	CcSEcCtD
Mannitol—Headache—Etoposide—testicular cancer	0.000332	0.000866	CcSEcCtD
Mannitol—Flatulence—Doxorubicin—testicular cancer	0.000332	0.000866	CcSEcCtD
Mannitol—Chest pain—Methotrexate—testicular cancer	0.000332	0.000864	CcSEcCtD
Mannitol—Arthralgia—Methotrexate—testicular cancer	0.000332	0.000864	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000329	0.000858	CcSEcCtD
Mannitol—Malaise—Epirubicin—testicular cancer	0.000329	0.000856	CcSEcCtD
Mannitol—Discomfort—Methotrexate—testicular cancer	0.000328	0.000854	CcSEcCtD
Mannitol—Nervousness—Doxorubicin—testicular cancer	0.000328	0.000854	CcSEcCtD
Mannitol—Vertigo—Epirubicin—testicular cancer	0.000327	0.000853	CcSEcCtD
Mannitol—Back pain—Doxorubicin—testicular cancer	0.000326	0.00085	CcSEcCtD
Mannitol—Cough—Epirubicin—testicular cancer	0.000318	0.000829	CcSEcCtD
Mannitol—Vision blurred—Doxorubicin—testicular cancer	0.000318	0.000828	CcSEcCtD
Mannitol—Convulsion—Epirubicin—testicular cancer	0.000316	0.000823	CcSEcCtD
Mannitol—Infection—Methotrexate—testicular cancer	0.000316	0.000823	CcSEcCtD
Mannitol—Nausea—Etoposide—testicular cancer	0.000315	0.000821	CcSEcCtD
Mannitol—Hypertension—Epirubicin—testicular cancer	0.000315	0.00082	CcSEcCtD
Mannitol—Ill-defined disorder—Doxorubicin—testicular cancer	0.000313	0.000815	CcSEcCtD
Mannitol—Nervous system disorder—Methotrexate—testicular cancer	0.000312	0.000812	CcSEcCtD
Mannitol—Chest pain—Epirubicin—testicular cancer	0.00031	0.000809	CcSEcCtD
Mannitol—Arthralgia—Epirubicin—testicular cancer	0.00031	0.000809	CcSEcCtD
Mannitol—Skin disorder—Methotrexate—testicular cancer	0.000309	0.000805	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000308	0.000803	CcSEcCtD
Mannitol—Discomfort—Epirubicin—testicular cancer	0.000307	0.000799	CcSEcCtD
Mannitol—Malaise—Doxorubicin—testicular cancer	0.000304	0.000792	CcSEcCtD
Mannitol—Vertigo—Doxorubicin—testicular cancer	0.000303	0.00079	CcSEcCtD
Mannitol—Oedema—Epirubicin—testicular cancer	0.000297	0.000775	CcSEcCtD
Mannitol—Hypotension—Methotrexate—testicular cancer	0.000297	0.000774	CcSEcCtD
Mannitol—Infection—Epirubicin—testicular cancer	0.000296	0.00077	CcSEcCtD
Mannitol—Cough—Doxorubicin—testicular cancer	0.000294	0.000767	CcSEcCtD
Mannitol—Convulsion—Doxorubicin—testicular cancer	0.000292	0.000761	CcSEcCtD
Mannitol—Nervous system disorder—Epirubicin—testicular cancer	0.000292	0.00076	CcSEcCtD
Mannitol—Hypertension—Doxorubicin—testicular cancer	0.000291	0.000759	CcSEcCtD
Mannitol—Tachycardia—Epirubicin—testicular cancer	0.00029	0.000757	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00029	0.000755	CcSEcCtD
Mannitol—Skin disorder—Epirubicin—testicular cancer	0.000289	0.000753	CcSEcCtD
Mannitol—Chest pain—Doxorubicin—testicular cancer	0.000287	0.000748	CcSEcCtD
Mannitol—Arthralgia—Doxorubicin—testicular cancer	0.000287	0.000748	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000285	0.000743	CcSEcCtD
Mannitol—Discomfort—Doxorubicin—testicular cancer	0.000284	0.000739	CcSEcCtD
Mannitol—Dyspnoea—Methotrexate—testicular cancer	0.000283	0.000738	CcSEcCtD
Mannitol—Hypotension—Epirubicin—testicular cancer	0.000278	0.000724	CcSEcCtD
Mannitol—Decreased appetite—Methotrexate—testicular cancer	0.000276	0.00072	CcSEcCtD
Mannitol—Oedema—Doxorubicin—testicular cancer	0.000275	0.000717	CcSEcCtD
Mannitol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000274	0.000715	CcSEcCtD
Mannitol—Fatigue—Methotrexate—testicular cancer	0.000274	0.000714	CcSEcCtD
Mannitol—Infection—Doxorubicin—testicular cancer	0.000273	0.000713	CcSEcCtD
Mannitol—Pain—Methotrexate—testicular cancer	0.000272	0.000708	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000271	0.000706	CcSEcCtD
Mannitol—Nervous system disorder—Doxorubicin—testicular cancer	0.00027	0.000703	CcSEcCtD
Mannitol—Tachycardia—Doxorubicin—testicular cancer	0.000269	0.0007	CcSEcCtD
Mannitol—Skin disorder—Doxorubicin—testicular cancer	0.000267	0.000697	CcSEcCtD
Mannitol—Dyspnoea—Epirubicin—testicular cancer	0.000265	0.000691	CcSEcCtD
Mannitol—Feeling abnormal—Methotrexate—testicular cancer	0.000262	0.000683	CcSEcCtD
Mannitol—Decreased appetite—Epirubicin—testicular cancer	0.000259	0.000674	CcSEcCtD
Mannitol—Hypotension—Doxorubicin—testicular cancer	0.000257	0.00067	CcSEcCtD
Mannitol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000257	0.000669	CcSEcCtD
Mannitol—Fatigue—Epirubicin—testicular cancer	0.000256	0.000668	CcSEcCtD
Mannitol—Pain—Epirubicin—testicular cancer	0.000254	0.000663	CcSEcCtD
Mannitol—Urticaria—Methotrexate—testicular cancer	0.000253	0.000658	CcSEcCtD
Mannitol—Body temperature increased—Methotrexate—testicular cancer	0.000251	0.000655	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000251	0.000653	CcSEcCtD
Mannitol—Dyspnoea—Doxorubicin—testicular cancer	0.000245	0.000639	CcSEcCtD
Mannitol—Feeling abnormal—Epirubicin—testicular cancer	0.000245	0.000639	CcSEcCtD
Mannitol—Decreased appetite—Doxorubicin—testicular cancer	0.000239	0.000623	CcSEcCtD
Mannitol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000238	0.000619	CcSEcCtD
Mannitol—Fatigue—Doxorubicin—testicular cancer	0.000237	0.000618	CcSEcCtD
Mannitol—Urticaria—Epirubicin—testicular cancer	0.000236	0.000616	CcSEcCtD
Mannitol—Pain—Doxorubicin—testicular cancer	0.000235	0.000613	CcSEcCtD
Mannitol—Body temperature increased—Epirubicin—testicular cancer	0.000235	0.000613	CcSEcCtD
Mannitol—Hypersensitivity—Methotrexate—testicular cancer	0.000234	0.00061	CcSEcCtD
Mannitol—Asthenia—Methotrexate—testicular cancer	0.000228	0.000594	CcSEcCtD
Mannitol—Feeling abnormal—Doxorubicin—testicular cancer	0.000227	0.000591	CcSEcCtD
Mannitol—Pruritus—Methotrexate—testicular cancer	0.000225	0.000586	CcSEcCtD
Mannitol—Hypersensitivity—Epirubicin—testicular cancer	0.000219	0.000571	CcSEcCtD
Mannitol—Urticaria—Doxorubicin—testicular cancer	0.000219	0.00057	CcSEcCtD
Mannitol—Body temperature increased—Doxorubicin—testicular cancer	0.000218	0.000567	CcSEcCtD
Mannitol—Diarrhoea—Methotrexate—testicular cancer	0.000217	0.000567	CcSEcCtD
Mannitol—Asthenia—Epirubicin—testicular cancer	0.000213	0.000556	CcSEcCtD
Mannitol—Pruritus—Epirubicin—testicular cancer	0.00021	0.000548	CcSEcCtD
Mannitol—Dizziness—Methotrexate—testicular cancer	0.00021	0.000548	CcSEcCtD
Mannitol—Diarrhoea—Epirubicin—testicular cancer	0.000204	0.00053	CcSEcCtD
Mannitol—Hypersensitivity—Doxorubicin—testicular cancer	0.000203	0.000528	CcSEcCtD
Mannitol—Vomiting—Methotrexate—testicular cancer	0.000202	0.000527	CcSEcCtD
Mannitol—Rash—Methotrexate—testicular cancer	0.0002	0.000522	CcSEcCtD
Mannitol—Dermatitis—Methotrexate—testicular cancer	0.0002	0.000522	CcSEcCtD
Mannitol—Headache—Methotrexate—testicular cancer	0.000199	0.000519	CcSEcCtD
Mannitol—Asthenia—Doxorubicin—testicular cancer	0.000197	0.000515	CcSEcCtD
Mannitol—Dizziness—Epirubicin—testicular cancer	0.000197	0.000513	CcSEcCtD
Mannitol—Pruritus—Doxorubicin—testicular cancer	0.000195	0.000507	CcSEcCtD
Mannitol—Vomiting—Epirubicin—testicular cancer	0.000189	0.000493	CcSEcCtD
Mannitol—Nausea—Methotrexate—testicular cancer	0.000189	0.000492	CcSEcCtD
Mannitol—Diarrhoea—Doxorubicin—testicular cancer	0.000188	0.000491	CcSEcCtD
Mannitol—Rash—Epirubicin—testicular cancer	0.000188	0.000489	CcSEcCtD
Mannitol—Dermatitis—Epirubicin—testicular cancer	0.000187	0.000488	CcSEcCtD
Mannitol—Headache—Epirubicin—testicular cancer	0.000186	0.000486	CcSEcCtD
Mannitol—Dizziness—Doxorubicin—testicular cancer	0.000182	0.000474	CcSEcCtD
Mannitol—Nausea—Epirubicin—testicular cancer	0.000177	0.00046	CcSEcCtD
Mannitol—Vomiting—Doxorubicin—testicular cancer	0.000175	0.000456	CcSEcCtD
Mannitol—Rash—Doxorubicin—testicular cancer	0.000174	0.000452	CcSEcCtD
Mannitol—Dermatitis—Doxorubicin—testicular cancer	0.000173	0.000452	CcSEcCtD
Mannitol—Headache—Doxorubicin—testicular cancer	0.000172	0.000449	CcSEcCtD
Mannitol—Nausea—Doxorubicin—testicular cancer	0.000163	0.000426	CcSEcCtD
